Godrej Agrovet Limited (GODREJAGRO)
₹632.85 +2.04% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Godrej Agrovet's revenue was ₹2,855 Cr (+9.2% year on year, +22.4% on the previous quarter), and net profit ₹128 Cr (-13.8% year on year); the operating margin was 8.4%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹2,855 | +9.2% | +22.4% |
| Operating profit | ₹240 | -10.9% | +72.8% |
| Net profit | ₹128 | -13.8% | +25.8% |
| EPS (₹) | 6.99 | -16.3% | +28.3% |
| Operating margin | 8.4% | — | — |
GODREJAGRO delivery percentage
NSE end-of-day data for
On Fri, 16 Oct 2026, 53.17% of the GODREJAGRO shares traded on NSE were taken to delivery, against the stock's own 20-session average of 46.67%. That is close to its usual level.
Delivery in the last 5 sessions: 29.6% · 39.5% · 49.9% · 52.2% · 53.2%
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Godrej Agrovet Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate from Registrar and Share Transfer Agent KFin Technologies confirms that all securities received for dematerialization were processed within 30 days. No operational disruptions or exceptions were reported. This is a standard quarterly administrative filing with zero impact on financial performance.
- Compliance certificate submitted under Regulation 74(5) of SEBI Regulations, 2018
- Pertains to the quarter ended September 30, 2026
- Registrar KFin Technologies confirmed requests processed within 30 days of receipt
- Filing formally dated and communicated on October 8, 2026
Godrej Agrovet announced the resignation of Rajavelu N.K, Chief Executive Officer of its Crop Care business, on September 21, 2026. The executive is stepping down to pursue an external opportunity, with his last working day set for November 24, 2026. A handover process will take place over the transitional weeks across this core business segment. The Crop Care vertical forms a strategic part of Godrej Agrovet's high-margin growth focus within its Rs 10,474 Cr TTM revenue base.
- Rajavelu N.K submitted resignation on September 21, 2026
- Last working day designated as November 24, 2026
- Resignation is from the position of Chief Executive Officer - Crop Care Business
- Reason cited is acceptance of an external opportunity
Rajavelu N.K., Chief Executive Officer of the Crop Care business at Godrej Agrovet Limited, has tendered his resignation to pursue an external opportunity. His last working day will be November 24, 2026. The resignation affects a key executive overseeing one of the company's strategic growth verticals, which contributes to agrochemical product lines in a firm generating Rs 10,474 Cr in TTM revenue. Godrej Agrovet will manage a transitional handover over the coming weeks.
- Rajavelu N.K. resigns from the position of CEO - Crop Care Business
- Effective last working day confirmed as 24th November 2026
- Resignation initiated via formal letter dated 21 September 2026
- Executive departure is attributed to pursuing an external opportunity
Godrej Agrovet announced the resignation of Mr. Rajavelu N.K., Chief Executive Officer of the Crop Care Business, effective close of business hours on November 24, 2026. Concurrently, Mr. Sivaram Yadavalli, currently Head of Strategy & Business Development since 2021, has been appointed as Interim CEO – Crop Care Business effective November 25, 2026. The Crop Care division forms a strategic high-margin vertical for the Rs 10,474 Cr TTM revenue agribusiness conglomerate.
- Rajavelu N.K. resigned as CEO – Crop Care Business, effective November 24, 2026
- Sivaram Yadavalli appointed as Interim CEO – Crop Care Business effective November 25, 2026
- Sivaram Yadavalli has led Strategy & Business Development at the company since 2021
- Resignation tendered on September 21, 2026, due to an external opportunity
Godrej Agrovet announced that Mr. Rajavelu N.K., Chief Executive Officer of the Crop Care business, has resigned to pursue an external opportunity, effective November 24, 2026. The Board has appointed Mr. Sivaram Yadavalli, currently Head of Strategy & Business Development, as the Interim CEO of the Crop Care business starting November 25, 2026. Mr. Yadavalli has led corporate strategy, M&A, and business transformation at the company since 2021. The leadership transition affects a core strategic business segment within Godrej Agrovet's ₹10,474 crore TTM revenue base.
- CEO of Crop Care business, Mr. Rajavelu N.K., resigned on September 21, 2026
- Cessation effective from close of business hours on November 24, 2026
- Mr. Sivaram Yadavalli appointed Interim CEO - Crop Care business effective November 25, 2026
- Mr. Yadavalli has served as Head – Strategy & Business Development at the company since 2021
Godrej Agrovet Limited has approved the appointment of Ms. Anushree Singh as Chief Human Resources Officer (CHRO), effective September 7, 2026. The appointment fills the vacancy created by the cessation of former Head of HR, Ms. Mallika Mutreja, on August 6, 2026. Ms. Singh has over two decades of HR leadership experience across companies such as JSW Energy, Avery Dennison, AkzoNobel, and Aditya Birla Group.
- Ms. Anushree Singh appointed as CHRO effective September 7, 2026
- Appointment follows cessation of Ms. Mallika Mutreja as Head - HR on August 6, 2026
- Appointee brings over two decades of global HR and organizational strategy experience
Godrej Agrovet Limited submitted a clarification to the National Stock Exchange of India on September 2, 2026, regarding a recent significant increase in trading volume. The company confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and SEBI PIT Regulations, 2015. It stated that there are no pending or undisclosed material developments that require disclosure to the exchanges. The filing serves as a standard response to NSE surveillance letter NSE/CM/Surveillance/17459 dated September 1, 2026.
- Response submitted on September 2, 2026, following NSE surveillance query dated September 1, 2026
- Company confirmed 100% compliance with Regulation 30 disclosure requirements under SEBI LODR Regulations
- Confirmed zero undisclosed events or price-sensitive developments under SEBI PIT Regulations, 2015
- Trading volume surge categorized as purely market-driven with no unannounced corporate actions
Godrej Agrovet Limited has informed the exchanges of scheduled one-on-one interactions with analysts and institutional investors. The meetings are scheduled on September 8, 11, 15, 16, 17, and 18, 2026, through physical meetings and video conferences. The company stated that discussions will rely on investor presentations already available on the company and exchange websites.
- Schedule includes 6 interaction dates between September 8, 2026 and September 18, 2026
- Meetings will be conducted in a One on One format via Physical or Video Conference mode
- Interactions include a full-day window on September 18, 2026 from 10.00 a.m. to 4.00 p.m.
- Company confirmed presentations will follow existing publicly disclosed materials
Godrej Agrovet Limited has notified the stock exchanges regarding scheduled interactions with analysts and institutional investors. The one-on-one meetings are slated to take place between September 8, 2026, and September 18, 2026, via physical or video conference modes. The company stated that discussions will be based on presentations already available in the public domain, with no unpublished price-sensitive information shared.
- Schedule covers 6 interaction dates: Sept 8, Sept 11, Sept 15, Sept 16, Sept 17, and Sept 18, 2026
- All meetings will be conducted in a One-on-One format via Physical or Video Conference
- Presentations during the sessions will align with existing filings on company and exchange websites
Godrej Agrovet Limited has scheduled six one-on-one interaction sessions with analysts and institutional investors between September 8, 2026, and September 18, 2026. The meetings will be conducted through physical interaction or video conference. The company stated that discussions will rely on standard presentation materials already available on public platforms and exchange websites.
- 6 one-on-one analyst/investor interaction slots scheduled between September 8, 2026, and September 18, 2026
- Scheduled meeting dates include September 8, 11, 15, 16, 17, and 18, 2026
- Meetings to take place via physical mode or video conference
- Discussions will adhere to existing presentations filed with stock exchanges
Godrej Agrovet Limited has announced a schedule of one-on-one analyst and institutional investor interactions across six separate dates between September 8, 2026, and September 18, 2026. The meetings will be conducted in physical or video conference mode. The company noted that presentations made during these interactions will be based on existing publicly available information on the company and exchange websites.
- Management to conduct one-on-one investor interactions on September 8, 11, 15, 16, 17, and 18, 2026
- Meeting formats include both physical and video conference modes
- Presentations will align with publicly available disclosures without sharing unpublished price-sensitive information
Godrej Agrovet Limited has informed the exchanges regarding its schedule of one-on-one interactions with analysts and institutional investors. The scheduled meetings will take place on September 8, 11, 15, 16, 17, and 18, 2026, through physical or video conference modes. The company clarified that discussions will be based on publicly available presentations without sharing any unpublished price-sensitive information.
- Management to conduct one-on-one investor interactions across 6 separate dates between September 8 and September 18, 2026
- Scheduled meeting dates include Sep 8, Sep 11, Sep 15, Sep 16, Sep 17, and Sep 18, 2026
- Modes of interaction will include physical meetings and video conferencing
- Presentations during the meets will align with already public materials on the exchange and company websites
Godrej Agrovet Limited has notified the exchanges regarding its upcoming schedule of one-on-one analyst and institutional investor meetings. A total of 6 interaction slots have been scheduled between September 8, 2026, and September 18, 2026, to be conducted via physical meetings or video conferences. The company stated that discussions will be based on existing publicly available investor presentations without sharing unpublished price-sensitive information.
- Scheduled 6 one-on-one analyst/investor interaction sessions between September 8, 2026, and September 18, 2026
- Interaction modes include both Physical and Video Conference formats
- Company presentations used will align with materials already submitted on exchange websites
Godrej Agrovet Limited has notified the stock exchanges regarding its schedule of one-on-one interactions with analysts and institutional investors. The meetings are slated across six separate dates: September 8, 11, 15, 16, 17, and 18, 2026, conducted via physical mode or video conference. The company stated that discussions will rely on standard presentations already accessible on exchange and company websites.
- Interactions scheduled across 6 distinct dates from September 8 to September 18, 2026
- Format: One-on-one sessions via Physical and Video Conference modes
- Company confirmed that discussions will refer to existing publicly available presentations
Godrej Agrovet Limited has announced a schedule of one-on-one analyst and institutional investor interactions across six different dates between September 8, 2026, and September 18, 2026. The meetings will be conducted via physical presence or video conference. The company stated that discussions will be based on presentations already available on company and stock exchange websites. This is a routine regulatory intimation under Regulation 30 of the SEBI Listing Regulations.
- Interactions scheduled across 6 dates between 08/09/2026 and 18/09/2026
- Format consists of one-on-one meetings via physical mode or video conference
- Company confirmed discussions will rely on already public investor presentations
Financial Performance
Revenue Growth by Segment
In Q2 FY26, Vegetable Oil revenue grew by 41% YoY, while Animal Feed revenue remained flat despite 18% volume growth in cattle feed. Stand-alone Crop Protection revenue declined sharply by 30% YoY. Consolidated revenue for H1 FY26 reached INR 5,182 Cr, an 8% YoY increase.
Geographic Revenue Split
Not disclosed in available documents; however, the company faces competition from both domestic and external players in the agro-chemicals segment.
Profitability Margins
Consolidated Net Profit Margin improved to 4.3% in FY25 from 3.8% in FY24. Operating Profit Margin rose to 8.7% in FY25 from 7.3% in FY24. In Q2 FY26, Vegetable Oil margins expanded to 22.4% due to higher realizations and extraction ratios.
EBITDA Margin
Operating margins were 9.0% in FY25 compared to 7.6% in FY24. Astec LifeSciences reported gross margins of 44% in Q2 FY26, a 4-5 year high, and is working toward breaking even on EBITDA.
Capital Expenditure
The company has a planned capital expenditure outlay of approximately INR 250-270 Cr per annum over the near term to support growth and recent acquisitions.
Credit Rating & Borrowing
CRISIL reaffirmed a 'Crisil A1+' rating for the INR 1,500 Cr Commercial Paper programme. The company maintains strong financial flexibility as part of the Godrej Group, allowing it to raise debt at competitive rates.
Operational Drivers
Raw Materials
Key raw materials include Fresh Fruit Bunches (FFB) for palm oil, and commodities for animal feed such as maize and soya. Crude Palm Oil (CPO) and Palm Kernel Oil (PKO) realizations are critical for the vegetable oil segment.
Capacity Expansion
Not disclosed in available documents; however, the company is investing in value-added businesses and has recently acquired the balance stakes in Creamline Dairy Products Limited and Godrej Foods Limited.
Raw Material Costs
Raw material costs are subject to high volatility; softening commodity prices in Q2 FY26 led to lower realizations in the animal feed segment despite volume growth. Vegetable oil margins benefited from higher oil extraction ratios.
Manufacturing Efficiency
Vegetable oil efficiency is measured by the oil extraction ratio, which improved in Q2 FY26. Astec LifeSciences is driving margins through process efficiencies and cost controls.
Strategic Growth
Expected Growth Rate
14%
Growth Strategy
Growth is driven by diversification into high-margin segments like Vegetable Oil (41% growth) and CDMO (30-31% margins). The company is focusing on process efficiencies, cost initiatives, and investing in value-added businesses while maintaining a healthy bottom-line growth trajectory of 14% YTD in H1 FY26.
Products & Services
Cattle feed, poultry feed, aqua feed, Crude Palm Oil (CPO), Palm Kernel Oil (PKO), agrochemicals (enterprise and CDMO), dairy products, and processed poultry.
Brand Portfolio
Godrej, Astec LifeSciences, Creamline Dairy Products, Godrej Foods.
New Products/Services
Not disclosed in available documents; however, the company is focusing on expanding its CDMO segment and value-added dairy/poultry products.
Market Expansion
Expansion is targeted through the palm oil business and increasing the application opportunities for agrochemicals in the crop protection segment.
Strategic Alliances
Recent acquisition of balance stakes in subsidiaries Creamline Dairy Products Limited (CDPL) and Godrej Foods Limited (GFL).
External Factors
Industry Trends
The industry is shifting toward diversified agri-businesses. Godrej Agrovet is positioning itself by reducing concentration in animal feed (now 48% of revenue) and growing its presence in specialized segments like CDMO and palm oil.
Competitive Landscape
Intense competition exists in the agro-chemicals business from both domestic and international players.
Competitive Moat
The 'Godrej' brand provides a significant moat, offering strong financial flexibility and favorable access to capital markets. Diversification across multiple agri-segments acts as a durable advantage against cyclicality.
Macro Economic Sensitivity
The business is sensitive to global and domestic demand-supply conditions and government regulations affecting selling prices and input availability.
Geopolitical Risks
Exposure to external players in the agro-chemicals business and global commodity price fluctuations.
Regulatory & Governance
Industry Regulations
Operations are subject to government regulations regarding agriculture, pollution norms, and import/export restrictions.
Taxation Policy Impact
The company's operations are influenced by changes in government regulations and tax laws.
Legal Contingencies
The company notes that important factors influencing operations include potential litigations, though specific case values are not disclosed in the provided text.
Risk Analysis
Key Uncertainties
Climatic risks such as extreme heat impacting palm oil yields and volatility in raw material prices which can impact margins by over 100 bps.
Third Party Dependencies
The company utilizes services of third parties for operations, posing a dependency risk.
Credit & Counterparty Risk
Receivables quality is reflected in a Debtors Turnover Ratio of 17.2; liquidity is strong with over INR 400 Cr in expected internal accruals.